Evidence map›Paper›PMID 41729456›Full record

ArticleMedical & biological engineering & computing2026

Computational modelling of the suppression of optic nerve fibre.

Ariastity Mega Pratiwi, Orsolya Kekesi, Alejandro Barriga-Rivera, Gregg Suaning

Abstract read
In one paragraph

Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariastity Mega PratiwiDepartment of Applied Physics III, University of Seville, Seville, Spain. apratiwi@us.es.ORCID http://orcid.org/0000-0002-2484-7439
Orsolya KekesiSchool of Biomedical Engineering, University of Sydney, Sydney, NSW, Australia.
Alejandro Barriga-RiveraDepartment of Applied Physics III, University of Seville, Seville, Spain.
Gregg SuaningSchool of Biomedical Engineering, University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal neuroprostheses aim to restore vision in degenerated retina but are hindered by poor activation selectivity. Suppressing subsets of optic nerve fibres based on diameter may improve selectivity by filtering superfluous activations. This study evaluates frequency-induced neuromodulation (FIN) using sinusoidal waveforms to achieve diameter-selective suppression. Computational models of retinal ganglion cells (RGCs) and optic nerve fibres (1.4, 2.8, and 4.3 μm) were subjected to sinusoidal currents from 10 to 10,000 Hz. The range of optic nerve fibre diameters was chosen to represent the optic nerve fibre population in rats. FIN could selectively filter action potential conduction, with the highest suppression probability at frequencies of 1000 Hz and above. The current amplitude required for suppression was influenced by the diameter of the fibres, the sinusoidal frequency of the FIN waveforms, and the ON-OFF typing of the RGC. It was observed that the membrane potential upstream of the FIN application site influenced the response to FIN. Selective suppression based on the fibre diameter is plausible, whereas selective functional-suppression based on the ON-OFF typing is less plausible owing to the small differences in their respective suppression thresholds. Filtering of this kind may improve the utility of retinal neuromodulation as a treatment to blindness.

Indexed as

Computer SimulationModels, NeurologicalNerve FibersOptic NerveAction PotentialsAnimalsElectric StimulationRatsRetinal Ganglion CellsComputational modellingOptic nerveSelective stimulationVisual neuroprosthesis

Identifiers

PMID41729456
PMCPMC13121198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.